Postpartum Cardiac Function

Condition: Preeclampsia, gestational hypertension

Eligibility

Key Inclusion Criteria

  • Pregnant women who received obstetrics care or are receiving cardiac care at Cedars-Sinai
  • Women with single pregnancies diagnosed with gestational hypertension and preeclampsia
  • Healthy women with single pregnancies (for comparison group)

Key Exclusion Criteria

  • Multiparity (e.g., twins, triplets)
  • History of cardiac disease or diabetes
  • Contraindications to cardiac magnetic resonance (pacemaker, other electronic device, severe claustrophobia)

Full Study Name

The Effects of Preeclampsia and Gestational Hypertension on Postpartum Cardiac Function as Assessed by Cardiac Magnetic Resonance (IRB no. 51004)

Summary

This study focuses on women who were diagnosed with gestational high blood pressure or preeclampsia during their recent pregnancy, or who are healthy and will be part of the comparison group. The purpose of the study is to evaluate whether gestational hypertension (high blood pressure) and preeclampsia (high blood pressure and protein in urine) causes heart problems after delivery. Heart function will be evaluated by conducting magnetic resonance imaging (MRI), in addition to other tests. The study will also measure biomarkers of heart function in the blood. A biomarker is a biological molecule found in blood, other body fluids, or tissues that may be a sign of a condition or disease.

Principal Investigator

C. Noel Bairey Merz, MD

Co-Investigator

Odayme Quesada, MD

Contact